Amarin Corporation PLC AMRN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:27 PM EDT
0.9005quote price arrow down-0.0175 (-1.9063%)
Volume
356,779
52 week range
0.65 - 1.49
Loading...
  • Open0.8946
  • Day High0.934
  • Day Low0.8911
  • Prev Close0.918
  • 52 Week High1.49
  • 52 Week High Date07/18/23
  • 52 Week Low0.65
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap369.81M
  • Shares Out410.67M
  • 10 Day Average Volume1.12M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change3.98

KEY STATS

  • Open0.8946
  • Day High0.934
  • Day Low0.8911
  • Prev Close0.918
  • 52 Week High1.49
  • 52 Week High Date07/18/23
  • 52 Week Low0.65
  • 52 Week Low Date11/01/23
  • Market Cap369.81M
  • Shares Out410.67M
  • 10 Day Average Volume1.12M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change3.98

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-6.21
  • Fwd P/E (NTM)-6.62
  • EBITDA (TTM)-22.922M
  • ROE (TTM)-10.30%
  • Revenue (TTM)277.455M
  • Gross Margin (TTM)63.61%
  • Net Margin (TTM)-18.96%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amarin Corporation PLC

 

Profile

MORE
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the...
Odysseas Kostas M.D.
Non-Executive Independent Chairman of the Board
Patrick Holt
President, Chief Executive Officer, Director
Thomas Reilly
Chief Financial Officer, Executive Vice President, Global Head of HR, Principal Accounting Officer
Jonathan Provoost
Executive Vice President, Chief Legal and Compliance Officer, Secretary
Aaron Berg
Executive Vice President, President - US
Address
Gemini House, Bartholomews Walk
Dublin
FK7 9JQ
Ireland

Top Peers

SYMBOLLASTCHG%CHG
VNDA
Vanda Pharmaceuticals Inc
4.78+0.10+2.03%
TVTX
Travere Therapeutics Inc
6.22+0.06+0.97%
CSTL
Castle Biosciences Inc
25.09+2.25+9.87%
EGRX
Eagle Pharmaceuticals Inc
4.28-0.12-2.73%
HROW
Harrow Inc
10.29-0.35-3.29%